Clinical Trials

Study Title:
GOG-3076 a Phase 3 Trial in Platinum-Resistant/Refractory Ovarian Cancer

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Whitney Graybill, at graybill@musc.edu.
Study Coordinator, Crystal Knox, at knoxc@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina